(Q52136917)

22 April 2018

title

Anti-human vWF monoclonal antibody, AJvW-2 Fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs. (English)

1 reference

22 April 2018

0 references

1 reference

Kageyama S

1

1 reference

22 April 2018

Yamamoto H

series ordinal

2

1 reference

22 April 2018

Nakazawa H

series ordinal

3

1 reference

22 April 2018

Yoshimoto R

series ordinal

4

1 reference

22 April 2018

publication date

1 March 2001

1 reference

22 April 2018

published in

Thrombosis Research

1 reference

22 April 2018

volume

101

1 reference

22 April 2018

issue

5

1 reference

22 April 2018

page(s)

395-404

1 reference

22 April 2018

Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Cyclic flow variations in a conscious dog model of coronary artery stenosis and endothelial injury correlate with acute ischemic heart disease syndromes in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Aurintricarboxylic acid in a canine model of coronary artery thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Enhanced shear-induced platelet aggregation in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900430-8

7 January 2021

10.1016/S0049-3848(00)00430-8

Identifiers

DOI

1 reference

22 April 2018

1 reference

22 April 2018